search
Company Information
USD
6.43
- (-1.7%)
NASDAQ:CCCC, C4 THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 2 May 2024 GMT-4
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

Address

490 Arsenal Way
Suite 120

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. Bruce L. Downey
Chairman of the Board/Director
Dr. Leonard M.J. Reyno
Chief Medical Officer
Mr. Andrew J. Hirsch
CEO/Director/President
Mr. Owen P. Hughes, Jr
Director
Dr. Donna Roy Grogan, M.D.
Director
Mr. Utpal Koppikar
Director
Dr. Kenneth C. Anderson, M.D.
Co-Founder/Director
Mr. Malcolm Salter
Director
Mr. Glenn Dubin
Director
Dr. Laura Bessen, M.D.
Director
Mr. Mark Mossler
Chief Accounting Officer
Ms. Kendra Adams
CFO/Treasurer
Ms. Jolie Siegel
Chief Legal Officer/Secretary
Ms. Kelly Schick
Other Executive Officer
Dr. Stewart Fisher, PhD
Chief Scientific Officer
Mr. Scott N. Boyle
Other Executive Officer

Ownership

Institution Holdings

Wasatch Advisors Inc.
7,138,949 (10.407%)
RA Capital Management, LP
4,878,000 (9.898%)
RA Capital Management, LLC
4,878,000 (7.111%)
Lynx1 Capital Management LP
3,122,219 (6.336%)
COMMODORE CAPITAL LP
3,800,000 (5.539%)
T. Rowe Price Associates, Inc.
2,558,480 (3.730%)
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
2,137,381 (3.116%)
Vanguard Group Inc
1,999,401 (2.915%)
Soleus Capital Management, L.P.
1,835,996 (2.676%)
BlackRock Inc
1,803,433 (2.629%)

Individual Holdings

Mr. Bruce L. Downey
489,542 (1.139%)
Mr. Andrew J. Hirsch
210,741 (0.428%)
Dr. Stewart Fisher, PhD
129,121 (0.262%)
Dr. Kenneth C. Anderson, M.D.
110,962 (0.225%)
Dr. Leonard M.J. Reyno
98,000 (0.199%)
Ms. Kendra Adams
82,039 (0.167%)
Mr. Scott N. Boyle
52,330 (0.106%)
Ms. Jolie Siegel
52,251 (0.106%)
Ms. Kelly Schick
52,251 (0.106%)
Dr. Donna Roy Grogan, M.D.
21,935 (0.045%)

Funds Holdings

Wasatch Ultra Growth Fund
2,842,637 (4.144%)
Vanguard Total Stock Market Index Fund
1,347,499 (1.964%)
Vanguard US Total Market Shares ETF
1,347,499 (1.964%)
Wasatch Small Cap Value Fund
1,031,624 (1.504%)
Vanguard Institutional Extnd Mkt Idx Tr
654,742 (0.954%)
Fidelity Extended Market Index Fund
252,941 (0.369%)
T. Rowe Price New Horizons Trust
237,468 (0.346%)
Bridgeway Ultra Small Company Market Fd
149,000 (0.217%)
BlackRock Extended Equity Market
89,527 (0.131%)
Wasatch Long/Short Alpha Fund
82,868 (0.121%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices